SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-003936
Filing Date
2022-03-16
Accepted
2022-03-16 16:41:20
Documents
12
Period of Report
2022-03-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K dvax-20220315.htm   iXBRL 8-K 47072
  Complete submission text file 0000950170-22-003936.txt   160980

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dvax-20220315_lab.xml EX-101.LAB 12936
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dvax-20220315_pre.xml EX-101.PRE 9589
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dvax-20220315.xsd EX-101.SCH 2501
6 EXTRACTED XBRL INSTANCE DOCUMENT dvax-20220315_htm.xml XML 4540
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 22745406
SIC: 2834 Pharmaceutical Preparations